Insider Trading activities of Biocryst Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Biocryst Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Biocryst Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Biocryst Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is BCRX. The reporting company's CIK number is 882796.
The total value of stock buying since 2005 is $19,133,715.
The total value of stock sales since 2005 is $57,771,386.
The total value of stock option exercises since 2005 is $6,299,549.


 1   2 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Biocryst Pharmaceuticals Inc (BCRX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2018-12 0 $0 83,922 $766,661 80,000 $96,000
2018-11 0 $0 134,295 $1,174,748 113,189 $333,700
2018-10 0 $0 13,100 $95,565 13,000 $46,382
2018-08 0 $0 62,500 $439,375 62,500 $88,750
2018-06 0 $0 42,112 $265,305 42,112 $108,648
2018-05 0 $0 0 $0 82,927 $117,756
2018-03 0 $0 0 $0 30,000 $97,800
2018-02 0 $0 0 $0 63,658 $207,524
2017-11 0 $0 64,310 $303,543 0 $0
2017-09 0 $0 54,250 $294,035 54,250 $231,647
2017-05 0 $0 0 $0 7,750 $36,657
2017-03 0 $0 16,250 $139,781 52,705 $156,208
2016-12 0 $0 3,250 $24,212 3,250 $12,285
2016-09 0 $0 8,357 $35,684 0 $0
2016-08 0 $0 4,097,031 $20,843,199 0 $0
2016-02 252,715 $1,621,223 0 $0 0 $0
2016-01 540,040 $3,906,771 0 $0 58,464 $166,500
2015-12 0 $0 6,052 $64,614 0 $0
2015-07 0 $0 3,500 $57,750 33,868 $399,981
2015-06 0 $0 122,514 $1,812,373 103,514 $161,640
2015-05 0 $0 3,000 $33,000 0 $0
2015-03 0 $0 60,000 $629,249 0 $0
2015-02 10,000 $102,700 0 $0 0 $0
2015-01 0 $0 0 $0 100,000 $129,000
2014-12 0 $0 137,899 $1,706,770 81,000 $267,479
2014-08 0 $0 10,000 $135,800 10,000 $54,500
2014-07 0 $0 3,125 $40,625 29,580 $114,780
2014-06 0 $0 6,250 $76,531 27,478 $139,671
2014-05 0 $0 0 $0 58,102 $256,687
2014-03 0 $0 100,166 $1,259,252 93,032 $466,161
2014-02 0 $0 0 $0 23,179 $99,669
2014-01 0 $0 0 $0 48,725 $149,350
2013-11 3,000 $18,570 0 $0 0 $0
2013-08 1,136,364 $5,000,001 0 $0 0 $0
2013-05 0 $0 0 $0 196,007 $235,208
2013-03 3,000 $3,690 0 $0 0 $0
2012-12 20,000 $30,200 0 $0 0 $0
2012-06 20,000 $63,680 0 $0 0 $0
2012-03 2,000 $10,430 5,088 $24,318 0 $0
2012-02 0 $0 30,912 $130,448 84,580 $35,239
2012-01 0 $0 60,624 $148,528 60,624 $72,748
2011-12 0 $0 4,542 $12,944 0 $0
2011-11 10,000 $27,500 0 $0 0 $0
2011-08 10,000 $25,190 0 $0 0 $0
2011-05 10,000 $35,600 0 $0 0 $0
2011-03 10,000 $33,990 22,615 $76,777 65,000 $78,000
2010-08 0 $0 2,500 $15,500 2,500 $3,000
2010-06 0 $0 1,250 $8,712 1,250 $1,500
2010-05 0 $0 1,250 $9,600 1,250 $1,500
2010-04 0 $0 58,904 $482,054 58,904 $163,979
2010-03 0 $0 26,500 $187,486 26,500 $45,800
2010-02 5,000 $33,300 15,146 $104,779 15,146 $53,354
2010-01 0 $0 35,464 $253,247 4,166 $10,748
2009-12 0 $0 151,367 $1,220,917 4,167 $10,750
2009-11 0 $0 452,800 $4,370,514 0 $0
2009-10 0 $0 16,000 $158,958 0 $0
2009-09 0 $0 20,000 $182,719 0 $0
2009-07 0 $0 2,468 $18,198 1,500 $4,890
2009-06 0 $0 481,846 $1,867,150 0 $0
2009-05 0 $0 1,142,217 $5,009,910 0 $0
2009-03 40,000 $48,880 0 $0 0 $0
2009-01 9,000 $14,535 0 $0 0 $0
2008-12 55,000 $81,400 0 $0 0 $0
2008-11 940,229 $951,238 0 $0 0 $0
2008-08 13,240 $38,996 0 $0 0 $0
2008-07 1,709 $4,822 0 $0 0 $0
2008-01 4,339 $15,195 0 $0 0 $0
2007-09 0 $0 20,000 $240,000 20,000 $127,500
2007-08 841,438 $6,583,646 0 $0 0 $0
2007-07 5,122 $36,134 0 $0 0 $0
2007-02 0 $0 0 $0 16,171 $72,898
2007-01 1,407 $12,161 0 $0 0 $0
2006-09 0 $0 5,600 $57,148 5,600 $26,096
2006-08 1,285 $11,565 0 $0 0 $0
2006-07 744 $7,209 0 $0 0 $0
2006-05 44,563 $316,089 26,243 $397,870 0 $0
2006-04 0 $0 10,000 $180,240 10,684 $174,950
2006-03 0 $0 184,162 $3,778,215 198,846 $1,193,127
2006-02 0 $0 19,200 $318,411 6,167 $40,363
2006-01 0 $0 0 $0 1,512 $9,124
2005-12 0 $0 566,667 $8,318,671 0 $0
2000-11 11,000 $99,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Biocryst Pharmaceuticals Inc insiders (BCRX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2018-12-04 Staab Thomas R Ii (Senior Vice President and CFO) Sale 3,922 9.45 37,062
2018-12-03 Stonehouse Jon P (President & CEO) Sale 80,000 9.12 729,599
2018-12-03 Stonehouse Jon P (President & CEO) Option Ex 80,000 1.20 96,000
2018-11-30 Barnes Alane P (Senior VP, Chief Legal Officer) Sale 44,290 9.07 401,710
2018-11-30 Barnes Alane P (Senior VP, Chief Legal Officer) Option Ex 25,000 1.42 35,500
2018-11-28 Erck Stanley C (Director) Option Ex 8,333 1.49 12,416
2018-11-23 Staab Thomas R Ii (Senior Vice President and CFO) Sale 3,500 9.66 33,810
2018-11-23 Staab Thomas R Ii (Senior Vice President and CFO) Option Ex 3,500 3.78 13,230
2018-11-21 Powell Lynne (Senior VP - CCO) Sale 14,455 9.04 130,600
2018-11-21 Powell Lynne (Senior VP - CCO) Option Ex 12,000 3.22 38,640
2018-11-21 Staab Thomas R Ii (Senior Vice President and CFO) Sale 12,000 9.24 110,939
2018-11-21 Staab Thomas R Ii (Senior Vice President and CFO) Option Ex 12,000 4.62 55,380
2018-11-20 Powell Lynne (Senior VP - CCO) Sale 15,277 8.56 130,847
2018-11-20 Powell Lynne (Senior VP - CCO) Option Ex 9,127 3.22 29,388
2018-11-20 Staab Thomas R Ii (Senior Vice President and CFO) Sale 11,123 8.66 96,325
2018-11-20 Staab Thomas R Ii (Senior Vice President and CFO) Option Ex 11,123 3.50 38,930
2018-11-19 Powell Lynne (Senior VP - CCO) Sale 193 8.30 1,601
2018-11-19 Powell Lynne (Senior VP - CCO) Option Ex 193 3.22 621
2018-11-19 Staab Thomas R Ii (Senior Vice President and CFO) Sale 75 8.30 622
2018-11-19 Staab Thomas R Ii (Senior Vice President and CFO) Option Ex 75 3.78 283
2018-11-08 Powell Lynne (Senior VP - CCO) Sale 5,280 8.15 43,032
2018-11-08 Powell Lynne (Senior VP - CCO) Option Ex 5,280 3.22 17,001
2018-11-08 Staab Thomas R Ii (Senior Vice President and CFO) Sale 13,415 8.20 109,935
2018-11-08 Staab Thomas R Ii (Senior Vice President and CFO) Option Ex 13,415 3.50 46,952
2018-11-07 Powell Lynne (Senior VP - CCO) Sale 300 8.00 2,400
2018-11-07 Powell Lynne (Senior VP - CCO) Option Ex 300 3.22 966
2018-11-07 Staab Thomas R Ii (Senior Vice President and CFO) Sale 672 8.00 5,376
2018-11-07 Staab Thomas R Ii (Senior Vice President and CFO) Option Ex 672 3.22 2,163
2018-11-05 Powell Lynne (Senior VP - CCO) Sale 100 8.00 800
2018-11-05 Powell Lynne (Senior VP - CCO) Option Ex 100 3.22 322
2018-11-05 Staab Thomas R Ii (Senior Vice President and CFO) Sale 215 8.00 1,720
2018-11-05 Staab Thomas R Ii (Senior Vice President and CFO) Option Ex 215 3.22 692
2018-11-02 Powell Lynne (Senior VP - CCO) Sale 1,000 8.00 8,000
2018-11-02 Powell Lynne (Senior VP - CCO) Option Ex 1,000 3.22 3,220
2018-11-02 Staab Thomas R Ii (Senior Vice President and CFO) Sale 10,856 7.87 85,436
2018-11-02 Staab Thomas R Ii (Senior Vice President and CFO) Option Ex 10,856 3.50 37,996
2018-11-01 Powell Lynne (Senior VP - CCO) Sale 1,544 7.51 11,595
2018-10-19 Powell Lynne (Senior VP - CCO) Sale 100 7.50 750
2018-10-19 Staab Thomas R Ii (Senior Vice President and CFO) Sale 3,150 7.45 23,467
2018-10-19 Staab Thomas R Ii (Senior Vice President and CFO) Option Ex 3,150 3.78 11,907
2018-10-03 Staab Thomas R Ii (Senior Vice President and CFO) Sale 1,072 7.36 7,884
2018-10-03 Staab Thomas R Ii (Senior Vice President and CFO) Option Ex 1,072 3.50 3,752
2018-10-02 Staab Thomas R Ii (Senior Vice President and CFO) Sale 8,778 7.23 63,464
2018-10-02 Staab Thomas R Ii (Senior Vice President and CFO) Option Ex 8,778 3.50 30,723
2018-08-09 Sheridan William P (Senior VP - CMO) Sale 62,500 7.03 439,375
2018-08-09 Sheridan William P (Senior VP - CMO) Option Ex 62,500 1.42 88,750
2018-06-01 Sheridan William P (Senior VP - CMO) Sale 42,112 6.30 265,305
2018-06-01 Sheridan William P (Senior VP - CMO) Option Ex 42,112 2.58 108,648
2018-05-17 Stonehouse Jon P (President & CEO) Option Ex 70,427 1.42 100,006
2018-05-15 Barnes Alane P (VP, General Counsel & Corp Sec) Option Ex 12,500 1.42 17,750
2018-03-06 Babu Yarlagadda S (Senior VP - Drug Discovery) Option Ex 30,000 3.26 97,800
2018-02-28 Barnes Alane P (VP, General Counsel & Corp Sec) Option Ex 6,709 3.26 21,871
2018-02-28 Stonehouse Jon P (President & CEO) Option Ex 56,949 3.26 185,653
2017-11-13 Sheridan William P (Senior VP - CMO) Sale 64,310 4.72 303,543
2017-09-18 Cohen Fred E (Director) Sale 54,250 5.42 294,035
2017-09-18 Cohen Fred E (Director) Option Ex 54,250 4.27 231,647
2017-05-22 Staab Thomas R Ii (Senior Vice President and CFO) Option Ex 7,750 4.73 36,657
2017-03-20 Staab Thomas R Ii (Senior Vice President and CFO) Sale 3,250 9.20 29,899
2017-03-20 Staab Thomas R Ii (Senior Vice President and CFO) Option Ex 3,250 3.78 12,285
2017-03-16 Staab Thomas R Ii (Senior Vice President and CFO) Option Ex 36,455 2.60 94,783
2017-03-10 Staab Thomas R Ii (Senior Vice President and CFO) Sale 3,250 9.06 29,445
2017-03-10 Staab Thomas R Ii (Senior Vice President and CFO) Option Ex 3,250 3.78 12,285
2017-03-08 Staab Thomas R Ii (Senior Vice President and CFO) Sale 6,500 8.43 54,762
2017-03-08 Staab Thomas R Ii (Senior Vice President and CFO) Option Ex 6,500 3.78 24,570
2017-03-06 Staab Thomas R Ii (Senior Vice President and CFO) Sale 3,250 7.90 25,675
2017-03-06 Staab Thomas R Ii (Senior Vice President and CFO) Option Ex 3,250 3.78 12,285
2016-12-19 Staab Thomas R Ii (Senior Vice President and CFO) Sale 3,250 7.45 24,212
2016-12-19 Staab Thomas R Ii (Senior Vice President and CFO) Option Ex 3,250 3.78 12,285
2016-09-14 Barnes Alane P (VP, General Counsel & Corp Sec) Sale 8,357 4.27 35,684
2016-08-25 Babu Yarlagadda S (Senior VP - Drug Discovery) Sale 30,000 4.06 121,799
2016-08-16 Baker Felix (10% Owner) Sale 990 4.29 4,246
2016-08-15 Baker Felix (10% Owner) Sale 400,000 4.83 1,931,200
2016-08-12 Staab Thomas R Ii (Senior Vice President and CFO) Sale 4,558 5.22 23,792
2016-08-12 Baker Felix (10% Owner) Sale 3,645,600 5.13 18,690,991
2016-08-11 Staab Thomas R Ii (Senior Vice President and CFO) Sale 1,306 5.05 6,595
2016-08-09 Staab Thomas R Ii (Senior Vice President and CFO) Sale 14,577 4.43 64,576
2016-02-05 Baker Felix (10% Owner) Buy 45,000 6.33 284,670
2016-02-04 Baker Felix (10% Owner) Buy 24,800 6.65 164,920
2016-02-03 Baker Felix (10% Owner) Buy 91,187 6.29 573,292
2016-02-02 Baker Felix (10% Owner) Buy 91,728 6.52 598,341
2016-01-29 Barnes Alane P (VP, General Counsel & Corp Sec) Option Ex 19,368 1.42 27,502
2016-01-28 Baker Felix (10% Owner) Buy 25,000 6.88 172,025
2016-01-27 Baker Felix (10% Owner) Buy 63,345 6.98 441,958
2016-01-22 Baker Felix (10% Owner) Buy 3,200 7.00 22,390
2016-01-21 Baker Felix (10% Owner) Buy 103,600 7.29 755,347
2016-01-20 Stonehouse Jon P (President & CEO) Option Ex 24,096 4.15 99,998
2016-01-20 Baker Felix (10% Owner) Buy 52,695 6.91 363,911
2016-01-19 Staab Thomas R Ii (Senior Vice President and CFO) Option Ex 15,000 2.60 39,000
2016-01-19 Baker Felix (10% Owner) Buy 92,200 7.12 656,740
2016-01-15 Baker Felix (10% Owner) Buy 200,000 7.47 1,494,400
2015-12-21 Staab Thomas R Ii (Senior Vice President and CFO) Sale 3,052 10.86 33,144
2015-12-17 Staab Thomas R Ii (Senior Vice President and CFO) Sale 3,000 10.49 31,470
2015-07-20 Staab Thomas R Ii (Senior Vice President and CFO) Sale 3,500 16.50 57,750
2015-07-15 Stonehouse Jon P (President & CEO) Option Ex 33,868 11.81 399,981
2015-06-22 Staab Thomas R Ii (Senior Vice President and CFO) Sale 3,750 16.00 60,000
2015-06-22 Staab Thomas R Ii (Senior Vice President and CFO) Option Ex 3,750 4.73 17,737
2015-06-19 Barnes Alane P (VP, General Counsel & Corp Sec) Sale 3,000 15.00 45,000
2015-06-19 Sheridan William P (Senior VP - CMO) Sale 70,389 15.05 1,059,354
2015-06-19 Sheridan William P (Senior VP - CMO) Option Ex 70,389 1.20 84,466
2015-06-19 Stonehouse Jon P (President & CEO) Sale 20,000 15.02 300,400
2015-06-19 Stonehouse Jon P (President & CEO) Option Ex 20,000 1.20 24,000
2015-06-19 Staab Thomas R Ii (Senior Vice President and CFO) Sale 6,675 15.00 100,125
2015-06-19 Staab Thomas R Ii (Senior Vice President and CFO) Option Ex 3,175 3.78 12,001
2015-06-18 Staab Thomas R Ii (Senior Vice President and CFO) Sale 9,700 13.92 134,994
2015-06-18 Staab Thomas R Ii (Senior Vice President and CFO) Option Ex 6,200 3.78 23,436
2015-06-05 Staab Thomas R Ii (Senior Vice President and CFO) Sale 6,000 12.75 76,500
2015-06-01 Staab Thomas R Ii (Senior Vice President and CFO) Sale 3,000 12.00 36,000
2015-05-18 Staab Thomas R Ii (Senior Vice President and CFO) Sale 3,000 11.00 33,000
2015-03-19 Babu Yarlagadda S (Senior VP - Drug Discovery) Sale 12,105 10.16 122,986
2015-03-05 Babu Yarlagadda S (Senior VP - Drug Discovery) Sale 37,400 10.59 396,066
2015-03-04 Babu Yarlagadda S (Senior VP - Drug Discovery) Sale 10,495 10.50 110,197
2015-02-20 Hutson Nancy J (Director) Buy 10,000 10.27 102,700
2015-01-08 Cohen Fred E (Director) Option Ex 100,000 1.29 129,000
2014-12-30 Sheridan William P (Senior VP - CMO) Sale 23,104 12.06 278,634
2014-12-30 Sheridan William P (Senior VP - CMO) Option Ex 23,104 1.42 32,807
2014-12-29 Sheridan William P (Senior VP - CMO) Sale 105,295 12.43 1,308,816
2014-12-29 Sheridan William P (Senior VP - CMO) Option Ex 48,396 4.11 198,762
2014-12-29 Staab Thomas R Ii (Senior Vice President and CFO) Sale 9,500 12.56 119,320
2014-12-29 Staab Thomas R Ii (Senior Vice President and CFO) Option Ex 9,500 3.78 35,910
2014-08-27 Staab Thomas R Ii (Senior Vice President and CFO) Sale 10,000 13.58 135,800
2014-08-27 Staab Thomas R Ii (Senior Vice President and CFO) Option Ex 10,000 5.45 54,500
2014-07-25 Staab Thomas R Ii (Senior Vice President and CFO) Option Ex 26,455 3.78 99,999
2014-07-01 Staab Thomas R Ii (Senior Vice President and CFO) Sale 3,125 13.00 40,625
2014-07-01 Staab Thomas R Ii (Senior Vice President and CFO) Option Ex 3,125 4.73 14,781
2014-06-23 Staab Thomas R Ii (Senior Vice President and CFO) Sale 3,125 12.49 39,031
2014-06-23 Staab Thomas R Ii (Senior Vice President and CFO) Option Ex 3,125 4.73 14,781
2014-06-17 Staab Thomas R Ii (Senior Vice President and CFO) Sale 3,125 12.00 37,500
2014-06-17 Staab Thomas R Ii (Senior Vice President and CFO) Option Ex 3,125 4.73 14,781
2014-06-03 Sheridan William P (Senior VP - CMO) Option Ex 21,228 5.19 110,109
2014-05-22 Staab Thomas R Ii (Senior Vice President and CFO) Option Ex 17,685 3.78 66,849
2014-05-09 Stonehouse Jon P (President & CEO) Option Ex 40,417 4.70 189,838
2014-03-31 Abercrombie George B (Director) Option Ex 4,000 1.71 6,840
2014-03-14 Staab Thomas R Ii (Senior Vice President and CFO) Sale 3,125 11.24 35,125
2014-03-14 Staab Thomas R Ii (Senior Vice President and CFO) Option Ex 3,125 4.73 14,781
2014-03-06 Lee Kenneth B Jr (Director) Sale 12,665 12.69 160,718
2014-03-06 Lee Kenneth B Jr (Director) Option Ex 22,917 3.80 87,084
2014-03-04 Barnes Alane P (VP, General Counsel & Corp Sec) Sale 40,734 12.63 514,470
2014-03-04 Barnes Alane P (VP, General Counsel & Corp Sec) Option Ex 31,174 4.25 132,333
2014-03-04 Babu Yarlagadda S (Senior VP - Drug Discovery) Sale 40,642 12.57 510,869
2014-03-04 Babu Yarlagadda S (Senior VP - Drug Discovery) Option Ex 28,816 7.32 210,933
2014-03-04 Staab Thomas R Ii (Senior Vice President and CFO) Sale 3,000 12.69 38,070
2014-03-04 Staab Thomas R Ii (Senior Vice President and CFO) Option Ex 3,000 4.73 14,190
2014-02-24 Babu Yarlagadda S (Senior VP - Drug Discovery) Option Ex 23,179 4.30 99,669
2014-01-14 Barnes Alane P (VP, General Counsel & Corp Sec) Option Ex 13,500 1.20 16,200
2014-01-13 Staab Thomas R Ii (Senior Vice President and CFO) Option Ex 35,225 3.78 133,150
2013-11-12 Abercrombie George B (Director) Buy 3,000 6.19 18,570
2013-08-01 Baker Bros. Investments, L.p. (10% Owner) Buy 1,136,364 4.40 5,000,001
2013-05-28 Sheridan William P (SR VP - CMO) Option Ex 16,407 1.20 19,688
2013-05-23 Stonehouse Jon P (President & CEO) Option Ex 179,600 1.20 215,520
2013-03-05 Abercrombie George B (Director) Buy 3,000 1.23 3,690
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of BCRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Biocryst Pharmaceuticals Inc (symbol BCRX, CIK number 882796) see the Securities and Exchange Commission (SEC) website.